| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/24/1991 | WO1991000924A1 Method for separating dna from a sample and kit therefor |
| 01/24/1991 | WO1991000920A2 Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector |
| 01/24/1991 | WO1991000917A1 Method for producing novel polyester biopolymers |
| 01/24/1991 | WO1991000916A2 Receptors for fibroblast growth factors |
| 01/24/1991 | WO1991000915A1 Aerosol beam microinjector |
| 01/24/1991 | WO1991000914A1 Production of antigens by self-assembly of polypeptide components |
| 01/24/1991 | WO1991000913A1 Inducible expression vectors |
| 01/24/1991 | WO1991000906A1 Chimeric and transgenic animals capable of producing human antibodies |
| 01/24/1991 | WO1991000904A1 Expression of retrovirus gag protein in eukaryotic cells |
| 01/24/1991 | WO1991000741A1 Use of bluetongue virus proteins as vaccine components |
| 01/24/1991 | WO1990015145A3 Poliovirus chimaeras |
| 01/24/1991 | WO1990014426A3 Saf polypeptide, gene, promoter and use for expression in streptomyces |
| 01/24/1991 | CA2075945A1 Use of bluetongue virus proteins as vaccine components |
| 01/24/1991 | CA2075896A1 Production of antigens by self-assembly of polypeptide components |
| 01/23/1991 | EP0409815A1 Glyphosate-tolerant 3-enolpyruvyl-3-phosphoshikimate synthases |
| 01/23/1991 | EP0409814A1 Variant proteins and polypeptides possessing enhanced affinity for immobilized-metal affinity matrices |
| 01/23/1991 | EP0409730A1 Tomato nitrate reductase gene cloning and expression vector |
| 01/23/1991 | EP0409696A1 Construct for the conditional immortalization of cells |
| 01/23/1991 | EP0409629A1 Ovary tissue transcriptional factors |
| 01/23/1991 | EP0409628A1 Compositions and methods for modulation of endogenous cytokinin levels |
| 01/23/1991 | EP0409625A1 Fruit-specific transcriptional factors |
| 01/23/1991 | EP0409472A1 Bone morphogenetic protein |
| 01/23/1991 | EP0409299A2 Mutant enzyme having reduced stability under industrial application conditions |
| 01/23/1991 | EP0409242A1 Monoclonal antibody against human CD4 peptide |
| 01/23/1991 | EP0409156A1 Fused yeast for foreign protein expression, methods of producing said yeast and methods of producing foreign proteins |
| 01/23/1991 | EP0409113A1 Human erythropoietin muteins, their production and their use |
| 01/23/1991 | EP0409098A1 The expression and secretion of mature human beta interleukin-1 in bacillus subtilis and means and methods for its achievement |
| 01/23/1991 | EP0409091A1 Antagonists of GM-CSF derived from the carboxyl terminus |
| 01/23/1991 | EP0409078A2 Method for sequencing of deoxyribonucleic acid |
| 01/23/1991 | EP0408945A1 Plasmides, their preparation and their use in obtaining a plasminogen activator |
| 01/23/1991 | EP0408859A2 Monoclonal antibodies to activated endothelial cells |
| 01/23/1991 | EP0408790A1 Recombinant protein receptor |
| 01/23/1991 | EP0408690A1 L-malic acid degrading yeast for wine making |
| 01/23/1991 | EP0408675A1 Detection of human tumor progression and drug resistance |
| 01/23/1991 | EP0408663A1 Peptides inhibitors of hiv induced cell fusions and syncytia formation |
| 01/23/1991 | EP0408661A1 Methods of generating desired amino-terminal residues in proteins |
| 01/23/1991 | EP0408658A1 Human papilloma virus typing method and nucleic acid probes used therein |
| 01/23/1991 | EP0408649A1 Bone and cartilage inductive compositions |
| 01/23/1991 | EP0408625A1 Diagnosis of mycobacterium bovis infection. |
| 01/23/1991 | EP0408603A1 Bacillus thuringiensis var. israelensis cryd toxin gene, protein and related insecticide compositions |
| 01/23/1991 | EP0387276A4 Method to produce immunodiagnostic reagents |
| 01/23/1991 | EP0189481B1 Insulin-like growth factor ii |
| 01/23/1991 | EP0183780B1 Distinguishing subsets of human cells |
| 01/22/1991 | WO1991002002A1 Recombinantly produced human membrane cofactor protein (mcp) |
| 01/22/1991 | WO1991001332A1 Feline calicivirus capsid protein and nucleotide sequence |
| 01/22/1991 | US4987078 Plasmid vectors for expression in Escherichia coli and/or Bacillus subtilis |
| 01/22/1991 | US4987074 Method for producing the HgiAI restriction endonuclease and methylase |
| 01/22/1991 | US4987073 Bacteriophage cloning system for the construction of directional DNA libraries |
| 01/22/1991 | US4987071 RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| 01/22/1991 | US4987070 Use of a 97 amino acid leader sequence from the E. coli B-galactosidase gene for the production of hanp and hptc as fusion proteins |
| 01/22/1991 | US4987069 Code for beta-lactamase |
| 01/22/1991 | US4987065 In vivo labelling of polynucleotide sequences |
| 01/22/1991 | CA1279276C Polypeptides and antibiotics characteristic of papillomavirus and use for the in vitro diagnostic, the prevention and/or the control of papillomavirus infections |
| 01/20/1991 | CA2021406A1 Expression and secretion of mature human beta interleukin-1 in bacillus subtilis and means and methods for its achievement |
| 01/20/1991 | CA2020729A1 Bone morphogenetic protein |
| 01/19/1991 | CA2021369A1 Tumor necrosis factor (tnf) inhibitor and method for obtaining the same |
| 01/18/1991 | WO1991004323A1 Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases |
| 01/18/1991 | CA2059266A1 Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases |
| 01/17/1991 | DE4020211A1 New rhinoviral DNA with mutation(s) in protease 2A region - and corresponding oligo:nucleotide(s) and oligopeptide(s), useful in test systems and as therapeutic competitive inhibitors |
| 01/16/1991 | EP0408461A1 Protein with urate oxidase activity, recombinant gene coding therefor, expression vector, micro-organisms and transformed cells |
| 01/16/1991 | EP0408403A1 Prevention of resistance development against Bacillus thuringiensis insecticidal crystal protein |
| 01/16/1991 | EP0408301A1 DNA coding for a polypeptide signal sequence in vaccinia virus |
| 01/16/1991 | EP0408295A2 Nucleic acid sequence amplification methods |
| 01/16/1991 | EP0408178A1 Immobilized protein G variants and the use thereof |
| 01/16/1991 | EP0408146A2 Method for the purification of therapeutically active recombinant acidic fibroblast growth factor |
| 01/16/1991 | EP0407942A2 Streptokinase proteins, corresponding genes, corresponding plasmid recombinants, corresponding transformants and processes for preparing same |
| 01/16/1991 | EP0407543A1 Mammalian gap-43 compositions and methods of use |
| 01/16/1991 | EP0407490A1 Production of human prourokinase |
| 01/16/1991 | EP0407462A1 Dna binding proteins including androgen receptor |
| 01/16/1991 | EP0407430A1 Therapeutic murine monoclonal antibody |
| 01/16/1991 | EP0407411A1 ACTIVITION OF NF-kB PRECURSOR. |
| 01/16/1991 | CN1011243B Regulatory site of expression for heterogenetic gene in yeast |
| 01/15/1991 | WO1991001330A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 01/15/1991 | US4985552 Process for obtaining chemically defined and reproducible polydeoxyribonucleotides |
| 01/15/1991 | US4985359 Vectors and methods for the construction of cDNA libraries |
| 01/15/1991 | US4985356 Cloning of DNA encoding human motilin precursor and expression of the precursor |
| 01/15/1991 | CA2062975A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 01/15/1991 | CA1279024C Compositions comprising an oligonucleotide sequence linked to an intercalationagent and an activable group, their synthesis and application as artificialsequence specific nucleases |
| 01/15/1991 | CA1279006C Assay for human breast cancer |
| 01/14/1991 | WO1991000909A1 Urate oxidase activity protein, recombinant gene coding therefor, expression vector, micro-organisms and transformed cells |
| 01/14/1991 | CA2020720A1 Method for the purification of therapeutically active recombinant acidic fibroblast growth factor |
| 01/13/1991 | CA2020740A1 Antigenically active proteins/peptides, and feline infectious peritonitis virus (fipv)-vaccines |
| 01/12/1991 | WO1991000911A1 Dna coding for a polypeptide signal sequence in vaccinia virus |
| 01/12/1991 | CA2063389A1 Dna coding for a polypeptide signal sequence in vaccinia virus |
| 01/12/1991 | CA2020828A1 Streptokinase proteins, corresponding genes, corresponding plasmid recombinants, corresponding transformants and processes for preparing same |
| 01/11/1991 | WO1991000870A1 Somatotropin analogs |
| 01/11/1991 | CA2057035A1 Somatotropin analogs |
| 01/10/1991 | WO1991000369A1 Biodegradation and recovery of gallium and other metal from integrated circuits |
| 01/10/1991 | WO1991000359A1 Particle-mediated transformation of animal somatic cells |
| 01/10/1991 | WO1991000358A1 A method for introducing molecules, particularly genetic material, into plant cells |
| 01/10/1991 | WO1991000357A1 New strain with filamentous fungi mutants, process for the production of recombinant proteins using said strain, and strains and proteins produced by said process |
| 01/10/1991 | WO1991000355A1 Genetic elements useful in production of active protein |
| 01/10/1991 | WO1991000354A1 Nucleic acid coding for the human testicular angiotensin conversion enzyme (eca) and its applications, in particular for the in vitro detection of said enzyme in the organism |
| 01/10/1991 | WO1991000353A2 MUTANT MICROBIAL α-AMYLASES WITH INCREASED THERMAL, ACID AND/OR ALKALINE STABILITY |
| 01/10/1991 | WO1991000352A1 Pestivirus nucleotide sequences and polypeptides |
| 01/10/1991 | WO1991000351A1 Fungal stress proteins |
| 01/10/1991 | WO1991000349A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
| 01/10/1991 | WO1991000348A1 Modified vp1/p2a regions of the rhinoviral system |
| 01/10/1991 | WO1991000347A1 Method of producing proteins with fviii activity and/or fviii derivatives |
| 01/10/1991 | WO1991000344A1 Enzyme production |